
DC PeptideRetatrutide
Ordered Retatrutide from DC Peptide? Mail in a sample (US only) and let us test it.
Test my supplyDC Peptide Retatrutide's main caveat is fill volatility: the latest lot tested +28% over stated amount. Under the purity-focus method, identity passes and 99.9–100% purity keep the profile relatively low-concern.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including DC Peptide rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 2 Nov 2026 | Pass | xatphh7 Tested | lab name | View COA | |||
| 24 Sep 2026 | Pass | xdxddqx Tested | lab name | View COA | |||
| 5 May 2026 | Pass | jnb5mwt Tested | lab name | View COA | |||
About DC Peptide test results from Finnrick
DC Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 3 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible DC Peptide peptides in this dataset are Retatrutide (3 tests), GHK-Cu (0 tests) and KPV (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 3 recent tests.
Ordered Retatrutide from DC Peptide? Mail in a sample (US only) and let us test it.
Test my supply